29
Oct
2009
Posted in MA Private: Synageva, Series C, X - Biosimilar, X - Oncology, X - Therapeutic
NOTE: Apologies for the delayed post release. 22″ of October snow yielded a slow start to the day… Waltham, MA-based Synageva Biopharma (formerly AviGenics) is focused on novel, next-generation and follow-on protein therapeutics that leverage their Synageva Expression Platform (SEP™). SEP™ is an integrated platform of proprietary vectors and protein production, processing and purification systems [...]
20
Oct
2009
Posted in IN Private: Endocyte, Series A, X - Drug Delivery, X - Folate, X - Oncology, X - Therapeutic
There is some robust and diverse activity transpiring at West Lafayette, IN-based Endocyte where not one, not two but three unique business activities are transpiring concurrently. These include: Addressing the issues of dosing and toxicity of oncologic therapeutics via a drug guidance system which is intended to improve specificity, safety and efficacy, and is payload [...]